LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Therapeutics Adoption Aerami Therapeutics specializes in advanced inhaled therapies for severe respiratory and cardiopulmonary conditions, presenting opportunities to supply specialized delivery platforms, inhalation devices, or complementary respiratory support products to support their pipeline expansion.

Clinical Trial Engagement With recent presentation of Phase 1 trial data for AER-901 and ongoing development efforts, there is a potential for collaboration in clinical trial supplies, diagnostics, or data management services to accelerate their research phases.

Growing Leadership and Funding The strategic leadership promotion to CEO and COO alongside their recent $5.4M funding round highlight a company in growth mode, opening doors for partnerships in investment consulting, strategic advisory, and integrated biotech service offerings.

Market Focus & Patient Impact Aerami’s focus on treating serious cardiopulmonary diseases such as pulmonary hypertension indicates opportunities to offer patient engagement platforms, educational tools, or health monitoring solutions tailored to their target populations.

Adjacent Technology Needs Utilizing cloud services and advanced digital infrastructure, Aerami may benefit from supply chain optimization, data analytics, and software development services to enhance their product administration platforms and streamline clinical data management.

Aerami Therapeutics Tech Stack

Aerami Therapeutics uses 8 technology products and services including Amazon Web Services, Amazon S3, RSS, and more. Explore Aerami Therapeutics's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Amazon S3
    Content Delivery Network
  • RSS
    Content Management System
  • Google Fonts API
    Font Scripts
  • Lodash
    Javascript Libraries
  • PWA
    Miscellaneous
  • WP Engine
    Platform As A Service
  • PHP
    Programming Languages

Media & News

Aerami Therapeutics's Email Address Formats

Aerami Therapeutics uses at least 2 format(s):
Aerami Therapeutics Email FormatsExamplePercentage
FLast@dancebiopharm.comJDoe@dancebiopharm.com
95%
First.Last@dancebiopharm.comJohn.Doe@dancebiopharm.com
5%
FLast@aerami.comJDoe@aerami.com
57%
Last@aerami.comDoe@aerami.com
43%

Frequently Asked Questions

Where is Aerami Therapeutics's headquarters located?

Minus sign iconPlus sign iconAerami Therapeutics's main headquarters is located at 2520 Meridian Pkwy 400 Durham, North Carolina 27713 US. The company has employees across 3 continents, including North AmericaEuropeOceania.

What is Aerami Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Aerami Therapeutics's main corporate office by phone at
+1-415-769-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aerami Therapeutics's official website and social media links?

Minus sign iconPlus sign iconAerami Therapeutics's official website is aerami.com and has social profiles on LinkedIn.

What is Aerami Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconAerami Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aerami Therapeutics have currently?

Minus sign iconPlus sign iconAs of March 2024, Aerami Therapeutics has approximately 16 employees across 3 continents, including North AmericaEuropeOceania. Key team members include Chief Executive Officer At Aerami Therapeutics: L. Y.Chief Executive Officer And Gbl: T. C.Chief Medical Officer: G. B.. Explore Aerami Therapeutics's employee directory with LeadIQ.

What industry does Aerami Therapeutics belong to?

Minus sign iconPlus sign iconAerami Therapeutics operates in the Biotechnology Research industry.

What technology does Aerami Therapeutics use?

Minus sign iconPlus sign iconAerami Therapeutics's tech stack includes Amazon Web ServicesAmazon S3RSSGoogle Fonts APILodashPWAWP EnginePHP.

What is Aerami Therapeutics's email format?

Minus sign iconPlus sign iconAerami Therapeutics's email format typically follows the pattern of FLast@dancebiopharm.com. Find more Aerami Therapeutics email formats with LeadIQ.

How much funding has Aerami Therapeutics raised to date?

Minus sign iconPlus sign icon As of March 2024, Aerami Therapeutics has raised $5.4M in funding. The last funding round occurred on Sep 20, 2022 for $5.4M.

When was Aerami Therapeutics founded?

Minus sign iconPlus sign iconAerami Therapeutics was founded in 2010.

Aerami Therapeutics

Biotechnology ResearchNorth Carolina, United States11-50 Employees

Aerami Therapeutics is breathing life into the treatment of serious and rare cardiopulmonary conditions with a mission-driven objective: develop products that help patients live longer and help them live better. We do this by combining precision medicines and advanced administration platforms that support ease-of-use and quality-of-life. 

Our lead program, AER-901 (inhaled imatinib) in pulmonary hypertension, has been intentionally designed to potentially reverse the damage caused by disease progression while overcoming many of the limitations of oral, parenteral, and other inhaled delivery technologies. 

To learn more, visit: https://aerami.com/

#Aerami #Cardiopulmonary #PulmonaryHypertension #PulmonaryArterialHypertension #PH #PAH #ILD #HeartDisease #LungDisease #InhaledTherapeutics #AER901 #AER601

Section iconCompany Overview

Headquarters
2520 Meridian Pkwy 400 Durham, North Carolina 27713 US
Phone number
+1-415-769-****
Website
aerami.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $5.4M

    Aerami Therapeutics has raised a total of $5.4M of funding over 9 rounds. Their latest funding round was raised on Sep 20, 2022 in the amount of $5.4M.

  • $1M$10M

    Aerami Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $5.4M

    Aerami Therapeutics has raised a total of $5.4M of funding over 9 rounds. Their latest funding round was raised on Sep 20, 2022 in the amount of $5.4M.

  • $1M$10M

    Aerami Therapeutics's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    L. Y.
    Chief Executive Officer At Aerami Therapeutics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. C.
    Chief Executive Officer And Gbl
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. B.
    Chief Medical Officer
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.